1282. Ceftolozane/Tazobactam Use in Critically Ill Patients Receiving Intermittent or Continuous Renal Replacement Therapy

BACKGROUND: Our hospital recommends ceftolozane/tazobactam (CT) as a broad-spectrum agent for treatment of Gram-negative bacilli in patients with a recent or current multidrug resistant (MDR) Pseudomonas infection. CT is utilized in patients who are on renal replacement therapy (RRT) yet little data...

Descripción completa

Detalles Bibliográficos
Autores principales: Henry, Molly, Puzniak, Laura A, Harris, Kelly, Van Schooneveld, Trevor C, Bergman, Scott J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644283/
http://dx.doi.org/10.1093/ofid/ofab466.1474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644283/
http://dx.doi.org/10.1093/ofid/ofab466.1474

Ejemplares similares